In summary, our study elucidated the pivotal role of SMAD4, a gene commonly mutated in PDAC, in attenuating PARP1-mediated DNA repair and contributing to radiotherapy resistance in pancreatic cancer. This evidence concerns the gene PARP1 and pancreatic neoplasm.